Spherity has developed an Ethereum-based credential revocation mechanism for use in the US pharmaceutical supply chain I have previously written about the importance of managing a registry of trusted issuers in the context of enterprise Self-sovereign Identity (SSI). A credential issuer, in turn, must maintain a registry of revoked verifiable credentials (VCs). [...]
Read MoreSo, here I was – a non-techie and SSI noob at a week-long expert geek event. What on earth was I going to do during the next 5 days?!
Read MoreCheck out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, hydroxychloroquine as […]
I have had discussions lately about the perception that an immunity passport is the same as a vaccination passport. This is not so. The choice of words matters! Let’s explore this from a basic immunological perspective.
Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance In terms of COVID-19, we’ve seen […]
Last month I wrote about being a mentor for one of the teams at the Stop COVID-19 hackathon by ConsenSys Health. My team was called dPlasma and amazingly won the first prize in the competition! ? Let’s […]
What is an adult scientist but a kid who’s never lost the curiosity. Neil deGrasse Tyson
Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed. At a glance We’ve seen more reliable COVID-19 serological […]
I am taking part as a mentor at ConsenSys Health‘s Stop COVID-19 hackathon. Oh, what was that? – Ah, yes. Why am I participating in a hackathon?
Check out my latest monthly review! It summarises Blue Steens’ latest posts and showcases some informative online content that I haven’t released elsewhere. Click to read >>>
Despite potential short-cuts, drug development is a lengthy and risky process that culminates in marketing approval. However, just because a drug achieves regulatory approval, does not mean that it will be instantly available to those in need. […]